Literature DB >> 10321954

Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules.

H Tomiyama1, T Sakaguchi, K Miwa, S Oka, A Iwamoto, Y Kaneko, M Takiguchi.   

Abstract

We attempted to identify and characterize HIV-1 CTL epitopes presented by HLA-B51 which is associated with a slow progression to AIDS. HLA-B*5101 stabilization assay showed that 33 out of 172 HIV-1 peptides carrying HLA-B*5101 anchor residues bound to HLA-B*5101. Seven peptides were suggested as HIV-1 CTL epitopes presented by HLA-B*5101 because the specific CTL was induced for these peptides in PBMC from three HIV-1 seropositive individuals carrying HLA-B51 by stimulation with HLA-B*5101 binding peptides. Analysis of these epitopes using the specific CTL clones confirmed that six of seven HIV-1 peptides are epitopes presented by HLA-B*5101. Three epitopes presented by HLA-B*5101 are highly conserved among the clade B strain, suggesting that the specific CTL for these epitopes might play an important role in recognition of HIV-1 infected cells. These epitopes will be useful to analyze CTL responses in HIV-1 infected individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321954     DOI: 10.1016/s0198-8859(98)00113-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  17 in total

1.  Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.

Authors:  Mark A Brockman; Denis R Chopera; Alex Olvera; Chanson J Brumme; Jennifer Sela; Tristan J Markle; Eric Martin; Jonathan M Carlson; Anh Q Le; Rachel McGovern; Peter K Cheung; Anthony D Kelleher; Heiko Jessen; Martin Markowitz; Eric Rosenberg; Nicole Frahm; Jorge Sanchez; Simon Mallal; Mina John; P Richard Harrigan; David Heckerman; Christian Brander; Bruce D Walker; Zabrina L Brumme
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

2.  Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101.

Authors:  Yuka Kawashima; Nozomi Kuse; Hiroyuki Gatanaga; Takuya Naruto; Mamoru Fujiwara; Sachi Dohki; Tomohiro Akahoshi; Katsumi Maenaka; Philip Goulder; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

3.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.

Authors:  Jagadish Chandrabose Sundaramurthi; Soumya Swaminathan; Luke Elizabeth Hanna
Journal:  Immunogenetics       Date:  2012-07-19       Impact factor: 2.846

5.  Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.

Authors:  Austin Huang; Joseph W Hogan; Sorin Istrail; Allison Delong; David A Katzenstein; Rami Kantor
Journal:  Future Virol       Date:  2012-05       Impact factor: 1.831

6.  Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity.

Authors:  Yuichi Yagita; Nozomi Kuse; Kimiko Kuroki; Hiroyuki Gatanaga; Jonathan M Carlson; Takayuki Chikata; Zabrina L Brumme; Hayato Murakoshi; Tomohiro Akahoshi; Nico Pfeifer; Simon Mallal; Mina John; Toyoyuki Ose; Haruki Matsubara; Ryo Kanda; Yuko Fukunaga; Kazutaka Honda; Yuka Kawashima; Yasuo Ariumi; Shinichi Oka; Katsumi Maenaka; Masafumi Takiguchi
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

7.  CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.

Authors:  T M Allen; B R Mothé; J Sidney; P Jing; J L Dzuris; M E Liebl; T U Vogel; D H O'Connor; X Wang; M C Wussow; J A Thomson; J D Altman; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Authors:  Yoshiyuki Yokomaku; Hideka Miura; Hiroko Tomiyama; Ai Kawana-Tachikawa; Masafumi Takiguchi; Asato Kojima; Yoshiyuki Nagai; Aikichi Iwamoto; Zene Matsuda; Koya Ariyoshi
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.

Authors:  Hiroko Tomiyama; Hirofumi Akari; Akio Adachi; Masafumi Takiguchi
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.

Authors:  A Duda; L Lee-Turner; J Fox; N Robinson; S Dustan; S Kaye; H Fryer; M Carrington; M McClure; A R McLean; S Fidler; J Weber; R E Phillips; A J Frater
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.